Clinical Trial

Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD

Study acronym: PRIMAvera
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to evaluate the efficacy and safety of the PRIMA System in patients with atrophic AMD. Eligible subjects will be implanted with the PRIMA Implant. The subjects will be assessed with various visual function and functional vision tests at defined timepoints throughout the clinical investigation with the PRIMA System (Implant and Visual Processor).
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2020-12-16; most recent amendment 2026-05-27.
Status change: Recruiting → Active, Not Recruiting 2023-02-07
Trial Details
NCT Number NCT04676854
Lead Sponsor Science Corporation
Conditions Geographic Atrophy
Enrollment 38 participants
Start Date 2020-11-24
Primary Completion 2024-02-01 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-01